Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. (JAGX) on February 17, 2022. The Company is incorporated in Delaware and its common stock trades on The NASDAQ Capital Market. The report addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the Company's compliance with continued listing standards.
Key Financial Metrics
This filing does not contain comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The only financial data point disclosed is that the Company currently holds stockholders' equity of at least $5 million, which qualifies it for consideration of a listing extension based on market value criteria.
Material Changes and Listing Status
On February 17, 2022, the Company received notice from Nasdaq that its common stock bid price had closed below the minimum $1.00 per share requirement for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). Consequently, the Company has been granted a 180-calendar-day grace period, expiring on August 16, 2022, to regain compliance. To maintain listing, the Company must achieve a closing bid price of at least $1.00 per share for 10 consecutive business days within this period.
Outlook, Risks, and Management Commentary
Management states it is diligently working to regain compliance with the minimum bid price requirement. However, the Company explicitly states there can be no assurance that it will succeed or that Nasdaq will grant a further extension if necessary. If the Company fails to regain compliance by August 16, 2022, its stock will be subject to delisting from Nasdaq. The filing includes standard forward-looking statement disclaimers regarding the uncertainty of achieving these plans.
Investor Verification Checklist
- Verify the current trading price of JAGX to assess the likelihood of meeting the $1.00 bid price requirement.
- Monitor the Company's stock price performance over the next 10 consecutive business days to determine if the initial compliance window is met.
- Review the Company's stockholders' equity status to confirm continued eligibility for a potential second grace period based on market value.
- Check for any subsequent filings regarding reverse stock splits or other corporate actions intended to address the low stock price.